-0.04 (-4.706%)
ASX:Live
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Valuation
Value
Consensus
Momentum
Price
Strong
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Telephone
61.3.8399.9419
Address
Level 3, Suite 69 574 Plummer Street Port Park-Building 2 Port Melbourne, Victoria (VIC) 3207
Description
Wellnex Life Ltd. engages in the provision of health and wellness products. It specializes in licensing and taking brands to the market in Australia and Asia. The company was founded by Lazarus Karasavvidis and Martin Glenister on May 6, 2011 and is headquartered in Port Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.59 - 1.75
Trade Value (12mth)
AU$10,789.00
1 week
18.31%
1 month
20.86%
YTD
-35.38%
1 year
-58.21%
All time high
100.39
EPS 3 yr Growth
-79.30%
EBITDA Margin
-39.80%
Operating Cashflow
-$7m
Free Cash Flow Return
-203.30%
ROIC
-409.80%
Interest Coverage
-2.80
Quick Ratio
0.30
Shares on Issue (Fully Dilluted)
26m
HALO Sector
Staples
Next Company Report Date
29-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
| Date | Announcements |
|---|---|
|
05 December 24 |
Trading Update
×
Trading Update |
|
04 December 24 |
Release From Voluntary Escrow
×
Release From Voluntary Escrow |
|
29 November 24 |
Results of Meeting
×
Results of Meeting |
|
29 November 24 |
Extension of Cleansing Prospectus
×
Extension of Cleansing Prospectus |
|
19 November 24 |
Completion of Placement
×
Completion of Placement |
|
19 November 24 |
Application for quotation of securities - WNX
×
Application for quotation of securities - WNX |
|
05 November 24 |
Update on Pain Away Deferred Consideration
×
Update on Pain Away Deferred Consideration |
|
31 October 24 |
Appendix 4C and Quarterly Report for Sep 2024 Quarter
×
Appendix 4C and Quarterly Report for Sep 2024 Quarter |
|
31 October 24 |
Extension of Cleansing Prospectus Offer Period
×
Extension of Cleansing Prospectus Offer Period |
|
31 October 24 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
|
24 October 24 |
Update on LSE Dual Listing
×
Update on LSE Dual Listing |
|
23 October 24 |
Appendix 3Y - Jeffrey Yeh
×
Appendix 3Y - Jeffrey Yeh |
|
23 October 24 |
Appendix 3Y - Zack Bozinovski
×
Appendix 3Y - Zack Bozinovski |
|
17 October 24 |
Appendix 3Y - Eric Jiang
×
Appendix 3Y - Eric Jiang |
|
17 October 24 |
Appendix 3Y - Andrew Vidler
×
Appendix 3Y - Andrew Vidler |
|
17 October 24 |
Appendix 3Y - George Karafotias
×
Appendix 3Y - George Karafotias |
|
15 October 24 |
Notification of cessation of securities - WNX
×
Notification of cessation of securities - WNX |
|
15 October 24 |
Completion of Share Consolidation
×
Completion of Share Consolidation |
|
09 October 24 |
Share Consolidation and ASX Code
×
Share Consolidation and ASX Code |
|
30 September 24 |
Extension of Cleansing Prospectus Offer Period
×
Extension of Cleansing Prospectus Offer Period |
|
30 September 24 |
FY24 Annual Report
×
FY24 Annual Report |
|
30 September 24 |
Wellnex Life Releases FY24 Annual Report
×
Wellnex Life Releases FY24 Annual Report |
|
30 September 24 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
|
26 September 24 |
Results of Meeting
×
Results of Meeting |
|
26 September 24 |
Constitution
×
Constitution |
Load More
Load Less
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
.svg)
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.
